Current News
Ensovibep, a SARS-CoV-2 antiviral DARPin, is safe and well tolerated in healthy volunteers: results of a first-in-human, ascending single-dose Phase 1 study
Ensovibep, a SARS-CoV-2 antiviral DARPin, is safe and well tolerated in healthy volunteers: results of a first-in-human, ascending single-dose Phase 1 study 2023-04-14 04:00:00
Empirical Optimization of Peptide Sequence and Nanoparticle Colloidal Stability: The Impact of Surface Ligands and Implications for Colorimetric Sensing
Empirical Optimization of Peptide Sequence and Nanoparticle Colloidal Stability: The Impact of Surface Ligands and Implications for Colorimetric Sensing 2023-04-14 04:00:00
Evaluation of a community health worker home visit intervention to improve child development in South Africa: A cluster-randomized controlled trial
Evaluation of a community health worker home visit intervention to improve child development in South Africa: A cluster-randomized controlled trial 2023-04-14 04:00:00